Drug Shortage Report for TEVA-PRAZOSIN

Last updated on 2022-09-23 History
Report ID 169951
Drug Identification Number 01934198
Brand name TEVA-PRAZOSIN
Common or Proper name TEVA-PRAZOSIN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) PRAZOSIN
Strength(s) 1MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C02CA
ATC description ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-22
Estimated end date 2022-10-10
Actual end date
Shortage status Actual shortage
Updated date 2022-09-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-09-23 English Compare
v2 2022-09-22 French Compare
v1 2022-09-22 English Compare

Showing 1 to 3 of 3